Andy Blackwell
Group Chief Science & Strategy Officer @Ieso Uk
Signup · Get unlimited contacts
WORK HISTORY
Group Chief Science & Strategy Officer @Ieso Uk
Cambridge, GB
Jan 2014 – Present · London, Cambridge, York, UK / RemoteDigital Mental Health | Clinical AI | Teletherapy | Product StrategyI have led scientific, clinical, and commercial strategy at one of the UK’s most advanced digital mental health companies. Over a decade, I have helped scale ieso from a research-stage startup to a product commissioned across the UK, making AI-enabled mental healthcare services available to over 20 million people.• Created and deployed the world’s first measurement-based digital therapy platform, treating thousands daily across NHS services.• Founded and led a clinical AI lab that developed the first psychotherapy language model to demonstrate human-parity outcomes.• Oversaw $100M+ in blended fundraising (VC, grant, philanthropic), guiding product and platform evolution across the UK and US.• Introduced responsible AI frameworks, engaging clinicians, patients, ethicists, and developers to guide safe and effective deployment.• Built and led high-performing teams across clinical research, engineering, data science, product, commercial, and operations.Focus areas: AI for mental health · Clinical-grade digital therapeutics · NHS and US market integration · Strategic growth · Lifespan neuropsychiatry
EDUCATION
University of St Andrews
M.A. (Hons) 1st Class, Psychology
University of St Andrews
PhD, Psychology / Cognitive Neuroscience
SKILLS
ABOUT ANDY BLACKWELL
Neuroscientist and healthcare technology entrepreneur with over 20 years of experience translating science into scalable, evidence-based solutions for mental health. I build and lead ventures that deliver measurable impact—scientifically, clinically, and commercially.Having seen firsthand the devastating effects that common mental health conditions can have on individuals and families, I’ve dedicated my career to improving outcomes through innovation. I’ve worked across the entire research-to-product spectrum: from foundational neuroscience and clinical neuropsychology to the development and commercialization of new medicines, regulated medical devices, clinical services, digital therapeutics, and clinical-grade artificial intelligence.At Cambridge Cognition, we developed and launched market-leading digital cognitive assessments, supporting the development and evaluation of more than 150 CNS drugs and medical devices—tools now used globally.At ieso Digital Health, we created the world’s first measurement-based digital therapy service, delivering quality care to thousands of patients daily. Together with an extraordinary team, I built a world-class clinical AI lab that has developed the first psychotherapy language model to demonstrate human-parity outcomes in clinical trials.My applied scientific work spans the life course—from child and adolescent mental health to older adult care—and addresses a wide range of neuropsychiatric conditions, including depression, anxiety, ADHD, OCD, dementia, schizophrenia, and Parkinson’s disease.I’ve grown companies from seed stage through to IPO and beyond. I’m passionate about responsible innovation and believe a fundamentally improved future for mental health is within reach—where scientifically rigorous, compassionate, and scalable solutions are available to everyone who needs them.If you’re building or investing in transformative healthcare ventures that aim to truly improve lives, I’d love to connect.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.